Investegate |NuCana plc Announcements | NuCana plc: NuCana Announces Enrollment of Required Number of Patients to Conduct Second Interim Analysis in the Phase III Biliary Tract Cancer Study

Investegate announcements from NuCana plc, NuCana Announces Enrollment of Required Number of Patients to Conduct Second Interim Analysis in the Phase III Biliary Tract Cancer Study

Related Keywords

United States ,United Kingdom ,Edinburgh ,City Of ,Hughs Griffith ,Marion Janic ,Chris Brinzey ,Company Annual Report On Form ,Exchange Commission ,Approval Program ,Nasdaq ,Nucana Announces Enrollment ,Required Number ,Conduct Second Interim Analysis ,Tract Cancer ,Patients Expected ,Enable Second Interim Analysis ,Second Half ,Interim Analysis ,Patients Remains ,First Half ,Either Interim Analysis May Support ,Objective Response Rate ,Chief Executive ,Overall Survival ,Private Securities Litigation Reform Act ,Annual Report ,Investegate Announcements ,Investegate Company Announcements ,Nucana Plc ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,